logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Hiroshi Yokouchi

department of respiratory medicine
H指数:24
被引数:2,578

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Treatment sequence after first-line immunotherapy in older adults with advanced NSCLC (NEJ057)

老年晚期非小细胞肺癌患者一线免疫治疗后治疗方案（NEJ057）

International Journal of Clinical Oncology
IF2.8
2026-10-030
PRE
Kohei Kushiro; Yoko Tsukita; Takehiro Tozuka; Shinobu Hosokawa; Toshiyuki Sumi; Mao Uematsu; Osamu Honjo; Ou Yamaguchi; Hiroyuki Kyoyama; Kyoji Tsurumi; Yohei Suzuki; Daisuke Ishikawa; Naruo Yoshimura; Naoko Matsumoto; Hiromi Nagashima; Ryotaro Kida; Hiroshi Yokouchi; Minehiko Inomata; Nobuhiro Kanaji; Taichi Takashina; Satoshi Morita; Kunihiko Kobayashi; Hajime Asahina
Tarlatamab in small cell lung cancer following platinum-based chemotherapy: subgroup analysis of Japanese patients from the DeLLphi-304 study

塔拉他马布在铂类化疗后的小细胞肺癌中的应用：DeLLphi-304研究中日本患者的亚组分析

International Journal of Clinical Oncology
IF2.8
2026-09-190
OAAI
Takayasu Kurata; Shunichi Sugawara; Hiroaki Akamatsu; Kazushige Wakuda; Koichi Azuma; Takayuki Takahama; Hiroshi Kagamu; Hiroshi Yokouchi; Miyako Satouchi; Shuji Murakami; Kadoaki Ohashi; Makoto Nishio; Kazumi Nishino; Hiroki Izumi; Hiroshi Tanaka; Taichi Miyawaki; Shuang Huang; Upen Patil; Jihyun Park; Tatsuya Yoshida
Prognostic Significance of Tumor-Cell VISTA Expression on Survival Outcomes in Nivolumab-Treated Pleural Mesothelioma: The HOT1901 Retrospective Multi-Institutional Study

Nivolumab治疗胸膜间皮瘤中肿瘤细胞VISTA表达对生存结局的预后意义：HOT1901回顾性多中心研究

ImmunoTargets and Therapy
IF4.4
2026-08-170
OA
Hiroshi Yokouchi; Hiroshi Nishihara; Yoshiyuki Kenmotsu; Kosuke Tsuji; Takayuki Kishikawa; Hajime Kikuchi; Eisaku Miyauchi; Yutaro Nagano; Kenya Kanazawa; Jun Sugisaka; Takayuki Ohkuri; Satoshi Oizumi
Author Correction: SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial

作者勘误：靶向SEZ6的抗体药物偶联物ABBV-706在晚期小细胞肺癌和实体瘤中的研究：一项1期临床试验

Nature Medicine
IF50
2026-06-290
OAAI
Lauren Averett Byers; Byoung Chul Cho; Alissa J. Cooper; Anne C. Chiang; Ji-Youn Han; Muhammad Furqan; Afshin Dowlati; Daniel Morgensztern; Kyriakos P. Papadopoulos; Noura J. Choudhury; María Vieito; Jair Bar; Joo-Hang Kim; Wallace Akerley; Tae Min Kim; Young-Chul Kim; Luis Paz-Ares; Myung-Ju Ahn; Hiroshi Yokouchi; Darius Meiman; Wijith Munasinghe; Oluwadamilola Ogunyankin; Nadine Jahchan; Song Wang; Cristiano Ferlini; Randy R. Robinson; Frederick J. Kohlhapp; Tammy Palenski; Guillermo Rivell; Pooja Hingorani; Sreenivasa Chandana
SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial

靶向SEZ6抗体偶联药物ABBV-706在晚期小细胞肺癌和实体瘤中的I期临床试验

Nature Medicine
IF50
2026-06-010
OAAI
Lauren Averett Byers; Byoung Chul Cho; Alissa J. Cooper; Anne C. Chiang; Ji-Youn Han; Muhammad Furqan; Afshin Dowlati; Daniel Morgensztern; Kyriakos P. Papadopoulos; Noura J. Choudhury; María Vieito; Jair Bar; Joo-Hang Kim; Wallace Akerley; Tae Min Kim; Young-Chul Kim; Luis Paz-Ares; Myung-Ju Ahn; Hiroshi Yokouchi; Darius Meiman; Wijith Munasinghe; Oluwadamilola Ogunyankin; Nadine Jahchan; Song Wang; Cristiano Ferlini; Randy R. Robinson; Frederick J. Kohlhapp; Tammy Palenski; Guillermo Rivell; Pooja Hingorani; Sreenivasa Chandana
Successful treatment of huntingtin-interacting protein-1-anaplastic lymphoma kinase-positive lung cancer with severe airway stenosis using silicone stent placement and alectinib

成功治疗伴有严重气道狭窄的亨廷顿相互作用蛋白-1-间变性淋巴瘤激酶阳性肺癌，采用硅酮支架置入和 Alecitinib 治疗。

RESPIRATORY INVESTIGATION
IF2
2025-11-010
PRE
Sato, Yuma; Kitai, Hidenori; Takashima, Yuta; Shinagawa, Naofumi; Sakakibara-Konishi, Jun; Ohkawa, Hiroya; Hatanaka, Kanako C.; Hatanaka, Yutaka; Yokouchi, Hiroshi; Konno, Satoshi
Biological impact of chemotherapy during treatment with EGFR tyrosine kinase inhibitors for non-small cell lung cancer positive for EGFR activating mutations

EGFR激活突变阳性的非小细胞肺癌患者在接受EGFR酪氨酸激酶抑制剂治疗期间化疗的生物学影响

Lung Cancer
IF4.4
2025-09-160
OAAI
Eiji Iwama; Kazuko Sakai; Taishi Harada; Shintaro Kanda; Shunichi Sugawara; Toshihide Yokoyama; Hirokazu Taniguchi; Kaoru Tanaka; Ryo Toyozawa; Kenichi Koyama; Yoshitaka Zenke; Gen Kida; Yasuhiko Nishioka; Hiroshi Yokouchi; Masayuki Hirose; Kazuto Nishio; Nobuyuki Yamamoto; Yuichiro Ohe; Isamu Okamoto
Phase 2 Trial of Combination Radiotherapy and Pembrolizumab Plus Chemotherapy in Patients With Previously Untreated Metastatic NSCLC: NJLCG 1902

先前未经治疗的转移性NSCLC患者联合放疗和Pembrolizumab加化疗的2期试验: NJLCG 1902

JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2025-02-010
OA
Tsukita, Yoko; Umezawa, Rei; Nakagawa, Taku; Anbai, Akira; Makiguchi, Tomonori; Tanaka, Hisashi; Horii, Yosuke; Suzuki, Aya; Morita, Ryo; Nogawa, Hitomi; Yokouchi, Hiroshi; Kimura, Nozomu; Jingu, Keiichi; Inoue, Akira; Sugiura, Hisatoshi; Miyauchi, Eisaku
Synchronous Oligometastasis and Oligoprogression as a Prognostic Marker in Patients With Extensive-Stage SCLC Treated With a Combination of Immune-Checkpoint Inhibitor and Chemotherapy (HOT2301)
JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2024-11-012
OA
Hashimoto, Kana; Morinaga, Daisuke; Asahina, Hajime; Ishidoya, Mina; Kikuchi, Hajime; Yokouchi, Hiroshi; Harada, Toshiyuki; Honjo, Osamu; Shigaki, Ryota; Takashina, Taichi; Fujita, Yuka; Takahashi, Mamoru; Kawai, Yasutaka; Kida, Ryotaro; Ito, Kenichiro; Sukoh, Noriaki; Takahashi, Ayumu; Hommura, Fumihiro; Ohhara, Yoshihito; Furuta, Megumi; Konno, Satoshi; Hosomi, Yukio; Oizumi, Satoshi
Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101)
TARGETED ONCOLOGY
IF4
2024-04-133
OAAI
Nishioka, Naoya; Imai, Hisao; Endo, Masahiro; Notsu, Akifumi; Doshita, Kosei; Igawa, Satoshi; Yokouchi, Hiroshi; Ninomiya, Takashi; Tokito, Takaaki; Soda, Sayo; Fujiwara, Takasato; Asao, Tetsuhiko; Nakamichi, Shinji; Kawamura, Takahisa; Inomata, Minehiko; Nakashima, Kazuhisa; Ito, Kentaro; Goto, Yasuhiro; Umeda, Yukihiro; Hirai, Soichi; Ushio, Ryota; Yokoo, Keiki; Takeda, Takayuki; Fukui, Tomoya; Ishihara, Masashi; Osaki, Takashi; Kubo, Sousuke; Fujiwara, Takumi; Yamamoto, Chie; Tsuda, Takeshi; Tamura, Nobumasa; Hosokawa, Shinobu; Chihara, Yusuke; Ikeda, Satoshi; Furuya, Naoki; Nakahara, Yoshiro; Miura, Satoru; Okamoto, Hiroaki
The effectiveness and safety of durvalumab after chemoradiotherapy for locoregional recurrence of completely resected non-small cell lung cancer: Real-world, multicenter, observational study (NEJ056)
ANNALS OF ONCOLOGY
IF65.4
2023-11-010
PRE
Horinouchi, H.; Furuta, M.; Yokota, I.; Yamaguchi, T.; Itoh, S.; Fukui, T.; Iwashima, A.; Kawashima, Y.; Miura, Y.; Tanaka, H.; Miyawaki, T.; Yokouchi, H.; Miura, K.; Saito, R.; Suzuki, H.; Kamoshida, T.; Uchinami, U.; Kato, T.; Kobayashi, K.; Asahina, H.
Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer
SCIENTIFIC REPORTS
IF3.9
2023-03-063
OAAI
Fujimoto, Daichi; Miura, Satoru; Tomii, Keisuke; Sumikawa, Hiromitsu; Yoshimura, Kenichi; Wakuda, Kazushige; Oya, Yuko; Yokoyama, Toshihide; Kijima, Takashi; Asao, Tetsuhiko; Tamiya, Motohiro; Nakamura, Atsushi; Yoshioka, Hiroshige; Tokito, Takaaki; Murakami, Shuji; Tamiya, Akihiro; Yokouchi, Hiroshi; Watanabe, Satoshi; Yamaguchi, Ou; Morinaga, Ryotaro; Jodai, Takayuki; Ito, Kentaro; Shiraishi, Yoshimasa; Kogure, Yoshihito; Shibaki, Ryota; Yamamoto, Nobuyuki
Effect of comprehensive cancer genomic profiling on therapeutic strategies and clinical outcomes in patients with advanced biliary tract cancer: A prospective multicenter study
FRONTIERS IN ONCOLOGY
IF3.3
2022-09-0214
OAAI
Takada, Kohichi; Kubo, Tomohiro; Kikuchi, Junko; Yoshida, Makoto; Murota, Ayako; Arihara, Yohei; Nakamura, Hajime; Nagashima, Hiroyuki; Tanabe, Hiroki; Sugita, Shintaro; Tanaka, Yumi; Miura, Ayana; Ohhara, Yoshihito; Ishiguro, Atsushi; Yokouchi, Hiroshi; Kawamoto, Yasuyuki; Mizukami, Yusuke; Ohnishi, Hirofumi; Kinoshita, Ichiro; Sakurai, Akihiro
Prognostic significance of OX40+ lymphocytes in tumor stroma of surgically resected small-cell lung cancer
ONCOIMMUNOLOGY
IF6.3
2021-09-183
OA
Yokouchi, Hiroshi; Nishihara, Hiroshi; Harada, Toshiyuki; Amano, Toraji; Ohkuri, Takayuki; Yamazaki, Shigeo; Kikuchi, Hajime; Oizumi, Satoshi; Uramoto, Hidetaka; Tanaka, Fumihiro; Harada, Masao; Akie, Kenji; Sugaya, Fumiko; Fujita, Yuka; Takamura, Kei; Kojima, Tetsuya; Higuchi, Mitsunori; Honjo, Osamu; Minami, Yoshinori; Watanabe, Naomi; Nishimura, Masaharu; Suzuki, Hiroyuki; Dosaka-Akita, Hirotoshi; Isobe, Hiroshi
Original Research Pembrolizumab plus chemotherapy-induced pneumonitis in chemo-nai•ve patients with non-squamous non-small cell lung cancer: A multicentre, retrospective cohort study
EUROPEAN JOURNAL OF CANCER
IF7.1
2021-06-0124
PRE
Fujimoto, Daichi; Miura, Satoru; Yoshimura, Kenichi; Wakuda, Kazushige; Oya, Yuko; Yokoyama, Toshihide; Yokoi, Takashi; Asao, Tetsuhiko; Tamiya, Motohiro; Nakamura, Atsushi; Yoshioka, Hiroshige; Haratani, Koji; Teraoka, Shunsuke; Tokito, Takaaki; Murakami, Shuji; Tamiya, Akihiro; Itoh, Shoichi; Yokouchi, Hiroshi; Watanabe, Satoshi; Yamaguchi, Ou; Tomii, Keisuke; Yamamoto, Nobuyuki
Phase 2 Study of YS110, a Recombinant Humanized Anti-CD26 Monoclonal Antibody, in Japanese Patients With Advanced Malignant Pleural Mesothelioma
JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2021-06-018
OAAI
Nakagawa, Kazuhiko; Kijima, Takashi; Okada, Morihito; Morise, Masahiro; Kato, Motoyasu; Hirano, Katsuya; Fujimoto, Nobukazu; Takenoyama, Mitsuhiro; Yokouchi, Hiroshi; Ohe, Yuichiro; Hida, Toyoaki; Aoe, Keisuke; Kishimoto, Takumi; Hirokawa, Masato; Matsuki, Hironori; Kaneko, Yutaro; Yamada, Taketo; Morimoto, Chikao; Takeda, Masayuki
Detection of somatic TP53 mutation in surgically resected small-cell lung cancer by targeted exome sequencing: association with longer relapse-free survival
HELIYON
IF3.6
2020-07-0111
OAAI
Yokouchi, Hiroshi; Nishihara, Hiroshi; Harada, Toshiyuki; Yamazaki, Shigeo; Kikuchi, Hajime; Oizumi, Satoshi; Uramoto, Hidetaka; Tanaka, Fumihiro; Harada, Masao; Akie, Kenji; Sugaya, Fumiko; Fujita, Yuka; Takamura, Kei; Kojima, Tetsuya; Higuchi, Mitsunori; Honjo, Osamu; Minami, Yoshinori; Watanabe, Naomi; Nishimura, Masaharu; Suzuki, Hiroyuki; Dosaka-Akita, Hirotoshi; Isobe, Hiroshi

研究方向

暂未获取到该数据
M
Masaharu Nishimura
H 指数:77论文数:1,320被引数:4.5万
S
Satoshi Oizumi
H 指数:42论文数:311被引数:1.2万
T
Toshiyuki Harada
H 指数:34论文数:245被引数:1.0万
H
Hiroshi Isobe
H 指数:39论文数:404被引数:1.1万
H
Hajime Kikuchi
H 指数:17论文数:111被引数:718
M
Masao Harada
H 指数:27论文数:128被引数:8,901
H
Hirotoshi Dosaka‐Akita
H 指数:56论文数:316被引数:1.0万
O
Osamu Honjo
H 指数:12论文数:60被引数:372
H
Hiroyuki Suzuki
H 指数:32论文数:452被引数:4,258
M
Megumi Furuta
H 指数:11论文数:58被引数:396